Ronan Andrew McLaughlin
@RonanAndrewMcL1
Followers
908
Following
4K
Media
9
Statuses
305
Irish Medical Oncology Trainee - Clinical Fellow Princess Margaret Cancer Centre, University Health Network, University of Toronto, Canada 🇨🇦 ☘️
Toronto, Ontario
Joined February 2020
RT @orlabdolan: Ireland becoming 'world leader' in cancer research via @rte .We are proud to support so much extrao….
rte.ie
Ireland is becoming a world leader in early detection cancer research, according to Breakthrough Cancer Research.
0
12
0
RT @UofTSurgery: The @UofTSurgery community mourns the loss of cherished colleague, Dr. Sean Cleary. "Sean has touched the lives of many of….
0
49
0
RT @PancreaticNA: Transforming the future of pancreatic cancer demands bold innovation, and that is precisely what @PancreaticNA is doing.….
pancreaticcancerna.org
Groundbreaking progress against pancreatic cancer took center stage at this year’s American Society of Clinical Oncology (ASCO) conference. Among the most anticipated presentations were new results...
0
2
0
RT @HalletJulie: Sub-typing to select NAT in #PDAC?. NeoPancONE 🇨🇦 #ASCO25 @CHPBAsurg.👥84 resectable PDAC.💉mFOLFIRINOX NAT.Median OS 34 mon….
0
16
0
RT @OrlaFitz10: This time of year is always the hardest! It has been my pleasure to work with this gang all year, who have been the most su….
0
3
0
RT @OncEd: 🫁 Thrilled to have Dr. Rosalyn Juergens from @JuravinskiRI with us as she shares key updates in lung cancer research and treatm….
0
1
0
RT @OncEd: 🇨🇦 On stage now: Dr. Ronan McLaughlin, Dr. Stephen Chia and Dr. Elena Elimova spotlighting Canadian Achievements in Cancer Resea….
0
1
0
RT @Aiims1742: Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but ra….
0
66
0
RT @ArndtVogel: Long-term outcomes and OS for zanidatamab + CTx in HER2+ mGEA: 4-year follow-up.#ASCO25.🔎Phs-2.👉ORR 76 %m DoR 18.7 mo.👉mPFS….
0
28
0
RT @CancerInstIRE: Congratulations to Prof Patrick Forde @FordePatrick and team @CancerInstIRE on this incredible piece of research publis….
0
8
0
RT @MarkOHaraMD: Proud moment when 2 of your former fellows are killing it on stage at #ASCO25. Congrats @mmwatt02 and @TimothyJBrownMD. @P….
0
4
0
RT @EmilyHarrold6: Delighted to be included of this effort to characterise differential responses to immunotherapy by underlying germline v….
0
6
0
RT @AudreyOHalloran: 🤩 Amazing work from Louise Kelly and the young onset cancer team @stjamesdublin @CancerInstIRE presenting their fantas….
0
9
0
RT @FlavioRochaMD: Promising work on #precisiononcology #PDAC.Would be great to subtype prior to select #NAT.Not all👞size fit all pts @OHSU….
0
3
0
RT @DavidOReilly2: Congratulations to Irish fellows @RonanAndrewMcL1 and @LochrinSarah for their oral presentations yesterday at ASCO. I lo….
0
5
0
RT @SylvesterCancer: Our very own Dr. Peter Hosein (@PeterHoseinMD) presented "Is Pancreas Subtyping Ready for Prime Time?" at #ASCO25 in a….
0
13
0
RT @ProfJohnCrown: Dr Sarah Lochrin on the #ASCO25 #ASCO 2025 podium where she delivered a great talk on single cycle neo-adjuvant ipilimu….
0
7
0
RT @RachelTClarke: Excellent presentation by @RonanAndrewMcL1 on pancreatic subtypes and GATA6 expression in resectable disease from NeoPan….
0
4
0
RT @MGMcNamara: Professional presentation by @RonanAndrewMcL1 also highlighting N.B. Adequate tissue for analysis: 98% research biopsies en….
0
5
0